Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.54USD
20 Jan 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.54
Open
$1.53
Day's High
$1.54
Day's Low
$1.51
Volume
887
Avg. Vol
5,229
52-wk High
$3.91
52-wk Low
$1.22

CBLI.OQ

Chart for CBLI.OQ

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company's programs are focused developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for CBLI.OQ.

Overall

Beta: 0.78
Market Cap(Mil.): $16.81
Shares Outstanding(Mil.): 10.99
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 44.85 30.38
EPS (TTM): -0.26 -- --
ROI: -31.58 -1.38 14.86
ROE: -29.17 -1.07 16.28

BRIEF-Cleveland BioLabs announces a $1.1 mln cost realignment with Department of Defense

* Announces a $1.1 million cost realignment with Department of Defense

Oct 11 2016

BRIEF-Cleveland Biolabs quarterly loss per share $0.17

* Quarterly loss per share $0.17 Source text for Eikon: Further company coverage:

Aug 15 2016

Earnings vs. Estimates